BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20008829)

  • 41. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
    Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
    Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aortic stiffness and kidney disease in an elderly population.
    Michener KH; Mitchell GF; Noubary F; Huang N; Harris T; Andresdottir MB; Palsson R; Gudnason V; Levey AS
    Am J Nephrol; 2015; 41(4-5):320-8. PubMed ID: 26067356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
    Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
    Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars.
    Shastri S; Katz R; Rifkin DE; Fried LF; Odden MC; Peralta CA; Chonchol M; Siscovick D; Shlipak MG; Newman AB; Sarnak MJ
    J Am Geriatr Soc; 2012 Jul; 60(7):1201-7. PubMed ID: 22724391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank.
    Yeh TS; Clifton L; Collister JA; Liu X; Hunter DJ; Littlejohns TJ
    Alzheimers Res Ther; 2023 Aug; 15(1):138. PubMed ID: 37605228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
    Sharma S; Denburg MR; Furth SL
    Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.
    Ito H; Antoku S; Izutsu T; Kusano E; Matsumoto S; Yamasaki T; Mori T; Togane M
    Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.
    Okparavero A; Foster MC; Tighiouart H; Gudnason V; Indridason O; Gudmundsdottir H; Eiriksdottir G; Gudmundsson EF; Inker LA; Levey AS
    Nephrol Dial Transplant; 2016 Mar; 31(3):439-47. PubMed ID: 26519958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystatin C, chronic kidney disease and retinopathy in adults without diabetes.
    Ng WY; Teo BW; Tai ES; Sethi S; Lamoureux E; Tien Yin W; Sabanayagam C
    Eur J Prev Cardiol; 2016 Sep; 23(13):1413-20. PubMed ID: 26928726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24).
    Drion I; van Hateren KJ; Joosten H; Alkhalaf A; Groenier KH; Kleefstra N; Wetzels JF; Bilo HJ
    Age Ageing; 2012 May; 41(3):345-50. PubMed ID: 22314695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
    Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
    Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.
    Canney M; Sexton DJ; O'Leary N; Healy M; Kenny RA; Little MA; O'Seaghdha CM
    J Epidemiol Community Health; 2018 Apr; 72(4):287-293. PubMed ID: 29332011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid decline of kidney function increases cardiovascular risk in the elderly.
    Shlipak MG; Katz R; Kestenbaum B; Siscovick D; Fried L; Newman A; Rifkin D; Sarnak MJ
    J Am Soc Nephrol; 2009 Dec; 20(12):2625-30. PubMed ID: 19892934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
    Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.